Search Results - "Isik, Selver"

Dynamic changes in systemic immune‐inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy by Demircan, Nazım Can, Atcı, Muhammed Mustafa, Demir, Metin, Işık, Selver, Akagündüz, Baran

“…Aim Systemic inflammation has been associated with chemoresistance and prognosis in solid tumors. Systemic immune‐inflammation index (SII) is a novel marker…”
Get full text

Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment by Telli, Tugba Akin, Ozguven, Salih, Alan, Ozkan, Filizoglu, Nuh, Ozturk, Mehmet Akif, Sariyar, Nisanur, Isik, Selver, Arikan, Rukiye, Demircan, Nazim Can, Basoglu, Tugba, Cetin, Ilknur Alsan, Ones, Tunc, Ercelep, Ozlem, Dane, Faysal, Yumuk, Perran Fulden

“…Objective We aimed to evaluate whether baseline 68 Ga-PSMA PET/CT-derived whole-body volumetric parameters could be used as predictive biomarkers for survival…”
Get full text

Efficacy of abiraterone acetate in castration‐resistant metastatic prostate cancer: A real‐world data analysis by Oyman, Abdilkerim, Başak, Mustafa, Özçelik, Melike, Özyükseler, Deniz Tataroğlu, Işık, Selver, Yıldırım, Mahmut Emre

“…Purpose The aim of this study was to evaluate the efficacy of abiraterone in patients with castration‐resistant metastatic prostate cancer. Materials and…”
Get full text

Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma by Aydin, Dincer, Sendur, Mehmet Ali, Kefeli, Umut, Ustaalioglu, Basak Bala, Aydin, Ozhan, Yildirim, Emre, Işik, Deniz, Ozcelik, Melike, Surmeli, Heves, Oyman, Abdilkerim, Isik, Selver, Sener, Nur, Ercelep, Ozlem, Hatice, Odabas, Aliustaoglu, Mehmet, Gumus, Mahmut

“…Abstract Background SBAs are rarely seen tumors.Data regarding the use of chemotherapy together with bevacizumab in advanced SBA patients are lacking Materials…”
Get full text

HER2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: a case report by Güren, Ali Kaan, Kocaaslan, Erkam, Ağyol, Yeşim, Majidova, Nargiz, Sever, Nadiye, Erel, Pinar, Çelebi, Abdussamet, Arikan, Rukiye, Işik, Selver, Sari, Murat, Bayoğlu, İbrahim Vedat, Köstek, Osman

“…Trastuzumab deruxtecan (T-DXd) is a novel anti-HER2 antibody-drug conjugate formed by the combination of trastuzumab and deruxtecan. It is used in human…”
Get full text

Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey by Ünal, Çağlar, Özmen, Tolga, Ordu, Çetin, Pilanci, Kezban Nur, İlgün, Ahmet Serkan, Gökmen, Erhan, Almuradova, Elvina, Özdoğan, Mustafa, Güler, Nilüfer, Uras, Cihan, Kara, Halil, Demircan, Orhan, Işık, Selver, Alço, Gül, Saip, Pınar, Aydın, Esra, Duymaz, Tomris, Çelebi, Filiz, Yararbaş, Kanay, Soybir, Gursel, Ozmen, Vahit

“…The Oncotype Dx recurrence score (ODx-RS) guides the adjuvant chemotherapy decision-making process for patients with early-stage hormone receptor-positive,…”
Get full text

Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy by Arıkan, Rukiye, Alkış, Hilal, Işık, Selver, Yaşar, Alper, Çelebi, Abdussamet, Majidova, Nargiz, Sever, Nadiye, Adlı, Mustafa, Demircan, Nazım C

“…The systemic inflammatory response (SIR) is known as an important factor associated with tumorigenesis and tumor progression, and can be reflected by…”
Get full text

Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens by Arikan, Rukiye, Atci, Muhammed Mustafa, Ay, Seval, Ayhan, Murat, Demircan, Nazim Can, Telli, Tugba Akin, Celebi, Abdussamet, Yasar, Alper, Isik, Selver, Celikel, Cigdem, Balvan, Ozlem, Bayoglu, Ibrahim Vedat, Kostek, Osman, Dane, Faysal, Yumuk, Perran Fulden

“…Mucinous colorectal adenocarcinoma (MCAC) is a distinct subtype of colorectal carcinoma (CRC). The prognostic and predictive significance of mucinous histology…”
Get full text

PTK-7 Expression in Gastric Cancer: A Prognostic Determinant by Özçelik, Melike, Ercelep, Özlem, Keser, Sevinç, Özdemir Barışık, Nagehan, Başar, Merve, Odabaş, Hatice, Oyman, Abdilkerim, Işık, Selver, Özçelik, Serhat, Aliustaoğlu, Mehmet

“…Protein tyrosine kinase-7, a regulatory protein in the Wnt signaling pathway, was highly overexpressed in various cancer types and assumed to be related to…”
Get full text

PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score by Bayoğlu, İbrahim Vedat, Hüseynov, Javid, Topal, Alper, Sever, Nadiye, Majidova, Nargiz, Çelebi, Abdussamet, Yaşar, Alper, Arıkan, Rukiye, Işık, Selver, Hacıoğlu, Muhammet Bekir, Ercelep, Özlem, Sarı, Murat, Erdoğan, Bülent, Hacıbekiroğlu, İlhan, Topaloğlu, Sernaz, Köstek, Osman, Çiçin, İrfan

“…Introduction: This study aimed to assess the role of the adjusted PNI-IMDC risk scoring system in stratifying the intermediate group of metastatic RCC patients…”
Get full text

Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study by Majidova, Nargiz, Seyyar, Mustafa, Bayraktar, Demet Işık, Dinç, Gülhan, İsgandarov, Elfag, Huseynov, Javid, Yaşar, Alper, Çelebi, Abdussamet, Sever, Nadiye, Kocaaslan, Erkam, Erel, Pınar, Ağyol, Yeşim, Güren, Ali Kaan, Arıkan, Rukiye, Işık, Selver, Ercelep, Özlem, Demirağ, Güzin, Kefeli, Umut, Köstek, Osman, Bayoğlu, İbrahim Vedat, Sarı, Murat

“…Many developing countries lack access to recommended first-line treatments for metastatic renal cell carcinoma (mRCC), such as immune checkpoint inhibitors…”
Get full text

The Relationship Between Vitamin D Levels and Receptor Activator of Nuclear Factor Ligand in Hashimoto’s Thyroiditis by Yavuzer, Hakan, Işık, Selver, Cengiz, Mahir, Bolayırlı, İbrahim Murat, Döventaş, Alper, Erdinçler, Deniz Suna

“…Aim: In order to analyze the relationship of Hashimoto’s thyroiditis with vitamin D and osteoclastogenic markers, we investigated vitamin D, osteoprotegerin…”
Get full text

Association of Pre-treatment Sarcopenia with Side Effects and Prognosis in Non-small Cell Lung Cancer Patients Receiving Erlotinib by demircan, nazım can

Get full text

Effect of Pretreatment Platelet Parameters on Survival in Limited Disease Small Cell Lung Cancer by Sakin, Abdullah, Yasar, Nurgul, Arici, Serdar, Demir, Cumhur, Geredeli, Caglayan, Aksaray, Ferdi, Isik, Selver, Cihan, Sener

“…Background: The aim of this study was to investigate the effect of platelet parameters before concurrent chemoradiotherapy (CCRT) on survival of patients with…”
Get full text

Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma by Telli, Tugba Akin, Bugdayci, Onur, Alan, Ozkan, Sariyar, Nisanur, Isik, Selver, Arikan, Rukiye, Yasar, Alper, Majidova, Nargiz, Celebi, Abdussamet, Erol, Bulent, Ozgen, Zerrin, Kostek, Osman, Bayoglu, Ibrahim Vedat, Ercelep, Ozlem, Dane, Faysal, Yumuk, Perran Fulden

“…This study aims to evaluate whether sarcopenia, measured by chest computed tomography (CT), affects survival outcomes and postoperative complications in soft…”
Get full text

Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters by Arikan, Rukiye, Ozguven, Salih, Telli, Tugba Akin, Isik, Selver, Demircan, Nazım Can, Basoglu, Tugba, Yasar, Alper, Celebi, Abdussamet, Filizoglu, Nuh, Ustun, Hilal Sagiroglu, Tinay, Ilker, Ones, Tunc, Turoglu, Halil Turgut, Erdil, Tanju Yusuf, Ozturk, Mehmet Akif, Ercelep, Ozlem, Bayoglu, Vedat, Kostek, Osman, Dane, Faysal, Yumuk, Perran Fulden

“…Prognostic markers in metastatic renal cell cancer (mRCC) are still insufficient. Any prognostic model objectively determines disease burden. To investigate…”
Get more information

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases by Kahraman, Seda, Karakaya, Serdar, Kaplan, Muhammed Ali, Goksu, Sema Sezgin, Ozturk, Akin, Isleyen, Zehra Sucuoglu, Hamdard, Jamshid, Yildirim, Sedat, Dogan, Tolga, Isik, Selver, Celebi, Abdussamet, Gulbagci, Burcu Belen, Paksoy, Nail, Dogan, Mutlu, Turk, Haci Mehmet, Bilici, Ahmet, Tatli, Ali Murat, Akbas, Sinem, Turan, Nedim, Hacibekiroglu, Ilhan, Dogu, Gamze Gokoz, Aydiner, Adnan, Sumbul, Ahmet Taner, Akyurek, Serap, Yalciner, Merih, Demirkazik, Ahmet, Gursoy, Pinar, Aykan, Musa Baris, Sahin, Elif, Karadag, İbrahim, Kostek, Osman, Er, Muhammed Muhiddin, Artaç, Mehmet, Duzkopru, Yakup, Aydin, Dincer, Isik, Deniz, Karakas, Yusuf, Kilickap, Saadettin, Erol, Cihan, Demir, Bilgin, Civelek, Burak, Ergun, Yakup, Akinci, Muhammed Bulent, Dogan, Izzet, Karadurmus, Nuri, Yumuk, Perran Fulden, Sendur, Mehmet Ali Nahit

“…Central nervous system (CNS) metastases can be seen at a rate of 30% in advanced stages for patients with non-small cell lung cancer (NSCLC). Growing evidence…”
Get full text

Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities by Telli, Tugba Akin, Alan, Ozkan, Demircan, Nazim Can, Sariyar, Nisanur, Arikan, Rukiye, Basoglu, Tugba, Yasar, Alper, Celebi, Abdussamet, Isik, Selver, Sofulu, Omer, Erol, Bulent, Turkoz, Huseyin Kemal, Ozgen, Zerrin, Ercelep, Ozlem, Dane, Faysal, Yumuk, Perran Fulden

“…Advanced age and presence of comorbidities affect prognosis and treatment decisions in patients with soft tissue sarcoma (STS). However, coeffect of age and…”
Get full text

The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing by Köstek, Osman, Demirel, Ahmet, Hacıoğlu, Muhammet Bekir, Tastekin, Didem, Karabulut, Senem, Gündogdu, Abidin, Sever, Nadiye, Ayhan, Murat, Çelebi, Abdussamed, Majidova, Nargiz, Yaşar, Alper, Ağyol, Yeşim, Erel, Pınar, Kocaaslan, Erkam, Güren, Ali Kaan, Arıkan, Rukiye, Isık, Selver, Ercelep, Ozlem, Goksu, Sema Sezgin, Alandag, Celal, Bilgetekin, İrem, Caner, Burcu, Sahin, Ahmet Bilge, Gulmez, Ahmet, Akagunduz, Baran, Kose, Fatih, Kaplan, Muhammet Ali, Dogan, Ender, Sakalar, Teoman, Guven, Deniz Can, Gurbuz, Mustafa, Ergun, Yakup, Karaagac, Mustafa, Turker, Sema, Ozkul, Ozlem, Yıldız, Birol, Sahin, Süleyman, Demiray, Atike Gokcen, Sari, Murat, Erdogan, Bülent, Hacıbekiroglu, İlhan, Çakmak Öksüzoğlu, Ömür Berna, Kilickap, Saadettin, Bilici, Ahmet, Bayoglu, İbrahim Vedat, Topaloglu, Sernaz, Cicin, İrfan

“…The prognosis of patients with advanced HCC can vary widely depending on factors such as the stage of the cancer, the patient's overall health, and treatment…”
Get full text

Prognostic Factors in Resected Biliary Tract Cancers and the Impact of Cytokeratin 20 Expression by ÇİL, İbrahim, OYMAN, Abdilkerim, IŞIK, Selver, AYHAN, Murat, ÖKTEN, İlker Nihat, YILMAZ, Mesut, ÖZÇELİK, Melike

Get full text